Hyperglycemia Is the Main Mediator of Prediabetes- and Type 2 Diabetes–Associated Impairment of Microvascular Function: The Maastricht Study
- Ben M. Sörensen1,2,
- Alfons J.H.M. Houben1,2,
- Tos T.J.M. Berendschot3,
- Jan S.A.G. Schouten3,
- Abraham A. Kroon1,2,
- Carla J.H. van der Kallen1,2,
- Ronald M.A. Henry1,2,4,
- Annemarie Koster5,6,
- Koen D. Reesink1,7,
- Pieter C. Dagnelie1,5,8,
- Nicolaas C. Schaper1,2,5,
- Casper G. Schalkwijk1,2,
- Miranda T. Schram1,2,4 and
- Coen D.A. Stehouwer1,2⇑
- 1School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, the Netherlands
- 2Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands
- 3University Clinic for Ophthalmology, Maastricht University Medical Center+, Maastricht, the Netherlands
- 4Heart and Vascular Center, Maastricht University Medical Center+, Maastricht, the Netherlands
- 5Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands
- 6Department of Social Medicine, Maastricht University, Maastricht, the Netherlands
- 7Department of Biomedical Engineering, Maastricht University, Maastricht, the Netherlands
- 8Department of Epidemiology, Maastricht University, Maastricht, the Netherlands
- Corresponding author: Coen D.A. Stehouwer, cda.stehouwer{at}mumc.nl.
Article Information
vol. 40 no. 8 e103-e105
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 21, 2017
- Accepted May 20, 2017
- Published in print July 21, 2017.
- Published online ahead of print June 16, 2017.
Article Versions
- Previous version (June 16, 2017 - 06:32).
- Previous version (June 20, 2017 - 07:20).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
Author Information
- Ben M. Sörensen1,2,
- Alfons J.H.M. Houben1,2,
- Tos T.J.M. Berendschot3,
- Jan S.A.G. Schouten3,
- Abraham A. Kroon1,2,
- Carla J.H. van der Kallen1,2,
- Ronald M.A. Henry1,2,4,
- Annemarie Koster5,6,
- Koen D. Reesink1,7,
- Pieter C. Dagnelie1,5,8,
- Nicolaas C. Schaper1,2,5,
- Casper G. Schalkwijk1,2,
- Miranda T. Schram1,2,4 and
- Coen D.A. Stehouwer1,2⇑
- 1School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, the Netherlands
- 2Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands
- 3University Clinic for Ophthalmology, Maastricht University Medical Center+, Maastricht, the Netherlands
- 4Heart and Vascular Center, Maastricht University Medical Center+, Maastricht, the Netherlands
- 5Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands
- 6Department of Social Medicine, Maastricht University, Maastricht, the Netherlands
- 7Department of Biomedical Engineering, Maastricht University, Maastricht, the Netherlands
- 8Department of Epidemiology, Maastricht University, Maastricht, the Netherlands
- Corresponding author: Coen D.A. Stehouwer, cda.stehouwer{at}mumc.nl.
Statistics from Altmetric.com
Article usage
In this Issue
August 2017, 40(8)
Hyperglycemia Is the Main Mediator of Prediabetes- and Type 2 Diabetes–Associated Impairment of Microvascular Function: The Maastricht Study
